Abstrakt

Introduction: Crohn’s disease (CD) is a chronic, inflammatory bowel disease that can affect any part of the digestive system. The ileocecal region is most commonly involved. Recently, there have been reports about Crohn’s disease isolated to the colon, which may be associated with different clinical behaviour and the need for various treatment options. Material/Methods: The study included 305 patients with CD, 171 women (56%) and 134 men (44%), hospitalized at the Department of Gastroenterology, University Hospital in Lodz. Among them, a group of 101 patients was identified with a lesion location only in the colon (L2) and 204 in the small intestine and colon (L1 and L3). An attempt was made to analyze patients with CD in terms of demographic data, clinical behavior of the disease and location of inflammatory lesions. Results: Among the features distinguishing the location of inflammatory lesions isolated to the colon (L2), statistically significantly less frequent occurrence of stenoses (21% at L2 location to 79% at L3, p <0.01) was observed compared to other locations. Moreover, patients with location of L2 lesions required surgery less frequently (27% with L2 vs. 73% L1 with L3, p <0.05). It was also demonstrated that among all the subjects, 42 patients underwent appendectomy before the diagnosis of CD, which constituted 19% of the L2 group patients to 81% of the L1 and L3 group (p <0.05). Conclusions: In CD there is a great diversity in the clinical behavior of the disease, which is undoubtedly related to its location. The obtained results indicate that in the group of patients with the location isolated to the colon, stenoses are less common and patients require surgery less frequently.

Przypisy

• 1. Arora U., Kedia S., Garg S., Bopanna S., Jain S., Yadav D.P., GoyalS., Gupta V., Sahni P., Pal S., Dash N.R., Madhusudhan K.S., SharmaR., Makharia G., Ahuja V.: Colonic Crohn’s disease is associated withless aggressive disease course than ileal or ileocolonic disease. Dig.Dis. Sci., 2018; 63: 1592–1599
  Google Scholar
• 2. Bartnik W.: Choroba Crohna jelita grubego. Pol. Arch. Med. Wewn.,1971; 47: 383–388
  Google Scholar
• 3. Bartnik W.: Inflammatory bowel disease – polish contribution. J.Physiol. Pharmacol. 2003; 54 Suppl., 3: 205–210
  Google Scholar
• 4. Cleynen I., Boucher G., Jostins L., Schumm P., Zeissig S., AhmadT., Andersen V., Andrews J.M., Annese V., Brand S., Brant S.R., ChoJ.C., Daly M.J., Dubinsky M., Duerr R.H., et al.: International InflammatoryBowel Disease Genetics Consortium. Inherited determinantsof Crohn’s disease and ulcerative colitis phenotypes: A genetic associationstudy. Lancet, 2016; 387: 156–167
  Google Scholar
• 5. Cleynen I., González J.R., Figueroa C., Franke A., McGovern D.,Bortlík M., Crusius B.JA., Vecchi M., Artieda M., Szczypiorska M.,Bethge J., Arteta D., Ayala E., Danese S., Hogezand R., et al.: Geneticfactors conferring an increased susceptibility to develop Crohn’sdisease also influence disease phenotype: results from the IBD EuropeanProject. Gut, 2013; 62: 1556–1565
  Google Scholar
• 6. Crohn B.B., Ginzburg L., Oppenheimer G.D.: Regional ileitis; apathologic and clinical entity. JAMA, 1932; 99; 1323–1329
  Google Scholar
• 7. Daperno M., D’Haens G., Van Assche G., Baert F., Bulois P., MaunouryV., Sostegni R., Rocca R., Pera A., Gevers A., Mary Y.V., ColombelJ.F., Rutgeerts P.: Development and validation of a new, simplifiedendoscopic activity score for Crohn’s disease: The SES-CD. Gastrointest.Endosc., 2004; 60: 505–512
  Google Scholar
• 8. Dulai P.S., Singh S., Casteele N.V., Boland B.S., Rivera-Nieves J.,Ernst P.B., Eckmann L., Barrett K.E., Chang J.T., Sandborn W.J.: Shouldwe divide Crohn’s disease into ileum-dominant and isolated colonicdiseases? Clin. Gastroenterol. Hepatol., 2019; 17: 2634–2643
  Google Scholar
• 9. Fiocchi C.: Inflammatory bowel disease pathogenesis: Where arewe? J. Gastroenterol. Hepatol., 2015; 30, Suppl. 1: 12–28
  Google Scholar
• 10. Guizzetti L., Zou G., Khanna R., Dulai P.S., Sandborn W.J., JairathV., Feagan B.G.: Development of clinical prediction models for surgeryand complications in Crohn’s disease. J. Crohns. Colitis, 2018;12: 167–177
  Google Scholar
• 11. Hancock L., Beckly J., Geremia A., Cooney R., Cummings F., PathanS., Guo C., Warren B., Mortensen N., Ahmad T., Jewell D.: Clinicaland molecular characteristics of isolated colonic Crohn’s disease.Inflamm. Bowel Dis., 2008; 14: 1667–1677
  Google Scholar
• 12. Li D., Haritunians T., Landers C., Potdar A.P., Yang S., Huang H.,Schumm P., Daly M., Targan S., McGovern D.: Late-onset Crohn’sdisease is a subgroup distinct in genetic and behavioral risk factorswith UC-like characteristics. Inflamm. Bowel Dis., 2018; 24: 2413–2422
  Google Scholar
• 13. Lockhart-Mummery H.E., Morson B.C.: Crohn’s disease (regionalenteritis) of the large intestine and its distinction fromulcerative colitis. Gut, 1960; 1: 87–105
  Google Scholar
• 14. Łodyga M., Eder P., Bartnik W., Gonciarz M., Kłopocka M., LinkeK., Małecka-Panas E., Radwan P., Rydzewska G.: Guidelines for themanagement of Crohn’s disease. Recommendations of the WorkingGroup of the Polish National Consultant in Gastroenterologyand the Polish Society of Gastroenterology. Gastroenterology Rev.,2013; 7: 317–338
  Google Scholar
• 15. Mulder D.J., Noble A.J., Justinich C.J., Duffin J.M.: A tale of twodiseases: The history of inflammatory bowel disease. J. CrohnsColitis, 2014; 8: 341–348
  Google Scholar
• 16. Parkes G.C., Whelan K., Lindsay J.O.: Smoking in inflammatorybowel disease: impact on disease course and insights into the aetiologyof its effect. J. Crohns Colitis, 2014; 8: 717–725
  Google Scholar
• 17. Sandborn W.J., Feagan B.G., Hanauer S.B., Lochs H., Löfberg R.,Modigliani R., Present D.H., Rutgeerts P., Schölmerich J., Stange E.F.,Sutherland L.R.: A review of activity indices and efficacy endpointsfor clinical trials of medical therapy in adults with Crohn’s disease.Gastroenterology, 2002; 122: 512–530
  Google Scholar
• 18. Satsangi J., Silverberg M.S., Vermeire S., Colombel J.F.: TheMontreal classification of inflammatory bowel disease: controversies,consensus, and implications. Gut, 2006; 55: 749–753
  Google Scholar
• 19. Solberg I.C., Cvancarova M., Vatn M.H., Moum B.: Risk matrixfor prediction of advanced disease in a population-based study ofpatients with Crohn’s disease. Inflamm. Bowel Dis., 2014; 20: 60–68
  Google Scholar
• 20. Solberg I.C., Vatn M.H., Hřie O., Stray N., Sauar J., Jahnsen J.,Moum B., Lygren I.: Clinical course in Crohn’s disease: Results of aNorwegian population based ten-year follow-up study. Clin. Gastroenterol.Hepatol., 2007; 5: 1430–1438
  Google Scholar
• 21. Subramanian S., Ekbom A., Rhodes J.M.: Recent advances inclinical practice: A systematic review of isolated colonic Crohn’sdisease: The third IBD? Gut, 2017; 66: 362–381
  Google Scholar
• 22. Wells C.: Ulcerative colitis and Crohn’s disease. Ann. R. Coll.Surg. Engl., 1952; 11: 105–120
  Google Scholar
• 23. Xu Y., Guo Z., Cao L., Xie T., Shen W., Li Y., Gong J., Zhu W.: Isolatedcolonic Crohn’s disease is associated with a reduced responseto exclusive enteral nutrition compared to ileal or ileocolonic disease.Clin. Nutr., 2019; 38: 1629–1635
  Google Scholar
• 24. Zhang Y.Z., Li Y.Y.: Inflammatory bowel disease: Pathogenesis.World J. Gastroenterol., 2014; 20: 91–99
  Google Scholar

Pełna treść artykułu